Cancer biotech raising $20m after delaying Nasdaq float
SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging funding to
SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging funding to
FEATURED
Once-a-day Alzheimer’s pill reaches US approval milestone
Builder to start innovative retirement living project in city
Work gets under way on cooperative housing for the elderly
Developers pitch luxurious retirement homes to win reluctant downsizers
French lessons in art of urban regeneration show ‘People come first’
Couple takes on new adventure as caretakers of the island
INNOVATION
